Floatz logo

Zofran

Infections Postoperative

University of CretePhase 4 / ApprovedActive
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Infections Postoperative cohort.

Asset / SponsorPhaseRating
Bxcl501
University of Crete
Phase 4BB
ROPIVACAINE
University of Crete
Phase 4BB
PROPOFOL
University of Crete
Phase 4BB
CISATRACURIUM ION
University of Crete
Phase 4BB
DROPERIDOL
University of Crete
Phase 4BB

View all 19 →

Same molecule, other indications

Zofran is also rated in:

NauseaDormant
BBB
Indicative ·
73 / 100
View asset →
VomitingDormant
BBB
Indicative ·
73 / 100
View asset →
Non-Hodgkin's LymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →